Annick Desjardins, Md

This study tests whether adding a drug called varlilumab to standard treatment and a personalized dendritic cell vaccine can help people with newly diagnosed glioblastoma live longer. About 43 participants will receive radiation, chemotherapy, and the vaccine, with some also gett…